| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,050 |
15,152 |
$3.44M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,933 |
11,480 |
$2.59M |
| G0378 |
Hospital observation service, per hour |
794 |
719 |
$735K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,164 |
1,079 |
$197K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
475 |
468 |
$107K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
604 |
410 |
$63K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
425 |
402 |
$36K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,982 |
6,485 |
$33K |
| 80053 |
Comprehensive metabolic panel |
3,938 |
3,313 |
$33K |
| T1015 |
Clinic visit/encounter, all-inclusive |
572 |
266 |
$26K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
78 |
77 |
$25K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
94 |
93 |
$23K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,885 |
1,721 |
$22K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
716 |
644 |
$18K |
| 87631 |
|
300 |
291 |
$14K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
299 |
281 |
$13K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,299 |
1,972 |
$13K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
961 |
741 |
$12K |
| 70450 |
Computed tomography, head or brain; without contrast material |
472 |
444 |
$11K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
95 |
95 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
753 |
729 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,545 |
1,269 |
$8K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
291 |
262 |
$7K |
| 96376 |
|
276 |
162 |
$7K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
120 |
109 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
531 |
509 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
181 |
169 |
$5K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
999 |
848 |
$5K |
| 84484 |
|
1,221 |
1,024 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
568 |
426 |
$4K |
| 83735 |
|
1,239 |
887 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
298 |
280 |
$3K |
| 76830 |
Ultrasound, transvaginal |
74 |
73 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
941 |
864 |
$3K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
28 |
27 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
95 |
95 |
$3K |
| 73564 |
|
136 |
133 |
$2K |
| 93971 |
|
49 |
41 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,607 |
2,484 |
$2K |
| 93975 |
|
30 |
30 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
149 |
86 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,675 |
3,969 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
252 |
233 |
$2K |
| 85610 |
|
747 |
605 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
38 |
38 |
$1K |
| 81001 |
|
921 |
842 |
$1K |
| 80050 |
General health panel |
26 |
24 |
$1K |
| 83605 |
|
406 |
364 |
$1K |
| 81025 |
|
730 |
676 |
$1K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
13 |
13 |
$1K |
| 83880 |
|
96 |
86 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
338 |
317 |
$968.48 |
| 83690 |
|
545 |
480 |
$954.29 |
| 71250 |
|
14 |
13 |
$937.21 |
| 85730 |
|
339 |
324 |
$936.20 |
| 80061 |
Lipid panel |
109 |
104 |
$871.14 |
| 85379 |
|
239 |
224 |
$841.22 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
20 |
14 |
$801.90 |
| 0002A |
|
23 |
23 |
$771.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
78 |
57 |
$730.53 |
| 81003 |
|
644 |
577 |
$721.85 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
26 |
24 |
$721.66 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,543 |
2,278 |
$703.10 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,100 |
863 |
$666.78 |
| 84703 |
|
115 |
109 |
$613.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19 |
12 |
$564.70 |
| 36415 |
Collection of venous blood by venipuncture |
306 |
223 |
$561.81 |
| 87077 |
|
193 |
182 |
$560.48 |
| 87040 |
|
82 |
74 |
$547.68 |
| 85027 |
|
76 |
75 |
$533.81 |
| 73030 |
|
54 |
53 |
$519.20 |
| 73610 |
|
46 |
44 |
$498.86 |
| 87641 |
|
14 |
14 |
$418.84 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
44 |
40 |
$417.44 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
44 |
40 |
$417.44 |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,016 |
1,584 |
$416.08 |
| J2704 |
Injection, propofol, 10 mg |
1,097 |
1,054 |
$413.52 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,156 |
1,801 |
$407.76 |
| 0001A |
|
23 |
23 |
$400.66 |
| 82550 |
|
206 |
174 |
$389.44 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
59 |
56 |
$387.74 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
190 |
123 |
$374.75 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
107 |
103 |
$372.50 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
13 |
12 |
$361.69 |
| 86140 |
|
89 |
84 |
$361.02 |
| 82962 |
|
515 |
344 |
$352.80 |
| 73630 |
|
44 |
44 |
$337.53 |
| J3490 |
Unclassified drugs |
887 |
657 |
$325.51 |
| 87186 |
|
106 |
101 |
$309.68 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
956 |
644 |
$215.73 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,009 |
846 |
$193.79 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
16 |
13 |
$155.45 |
| 90714 |
|
13 |
12 |
$140.56 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
578 |
521 |
$140.38 |
| 84100 |
|
127 |
103 |
$139.58 |
| J2060 |
Injection, lorazepam, 2 mg |
473 |
402 |
$130.86 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
928 |
713 |
$126.30 |
| 86900 |
|
57 |
52 |
$122.50 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
13 |
13 |
$116.34 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
409 |
374 |
$108.96 |
| 82607 |
|
30 |
25 |
$105.52 |
| 82248 |
|
79 |
75 |
$102.07 |
| 85651 |
|
53 |
49 |
$87.12 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
18 |
14 |
$82.86 |
| 99406 |
|
15 |
13 |
$81.20 |
| 87420 |
|
14 |
14 |
$77.14 |
| 86901 |
|
30 |
26 |
$59.55 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
179 |
151 |
$58.49 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
420 |
392 |
$34.57 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
353 |
336 |
$34.23 |
| J1815 |
Injection, insulin, per 5 units |
51 |
26 |
$31.89 |
| J1644 |
Injection, heparin sodium, per 1000 units |
104 |
42 |
$25.23 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
370 |
215 |
$4.60 |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
12 |
12 |
$0.80 |
| 00000 |
|
1,039 |
323 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
12 |
12 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
368 |
140 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
155 |
146 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
55 |
42 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
150 |
140 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
43 |
38 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
15 |
13 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
14 |
13 |
$0.00 |